Clinical and histopathologic characteristics and outcomes of patients with Psoriatic Arthritis undergoing arthroplasty [0.03%]
银屑病关节炎患者行人工关节置换术的临床、病理特征及结局分析
Josh Mukherjee,Amit Lakhanpal,Melanie H Smith et al.
Josh Mukherjee et al.
Objective: Patients with psoriatic arthritis (PsA) experience higher postoperative complication rates after total hip (THA) or total knee arthroplasty (TKA) than osteoarthritis patients, but contributing factors to this r...
Single-Cell and Spatial Omics Uncover Disease-Specific Synovial Landscapes in Rheumatoid and Psoriatic Arthritis [0.03%]
单细胞和空间组学揭示类风湿关节炎和银屑病关节炎中具有疾病特异性的滑膜景观
Alexandra Khmelevskaya,Christopher Ritchlin,Caroline Ospelt et al.
Alexandra Khmelevskaya et al.
At the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2025 annual meeting in Bogotá, Columbia, Alexandra Khmelevskaya and Dr. Christopher Ritchlin presented a basic symposium on synovial immunopathology. Th...
Bimekizumab Long-Term Safety and Efficacy Across the Spectrum of Axial Spondyloarthritis Over 3 Years: Results from Two Phase 3 Studies [0.03%]
Bimekizumab治疗轴型脊柱关节炎长期安全性和疗效：为期三年的两项III期研究结果
Xenofon Baraliakos,Atul Deodhar,Désirée van der Heijde et al.
Xenofon Baraliakos et al.
Objective: 2-year safety and efficacy of bimekizumab, a dual IL-17A and IL-17F inhibitor, has been demonstrated across the full disease spectrum of axial spondyloarthritis (axSpA). We report bimekizumab long-term safety a...
Overall and sex-specific predictors of secukinumab effectiveness in European patients with psoriatic arthritis: results from the EuroSpA collaboration [0.03%]
欧洲银屑病关节炎患者的secukinumab疗效的整体预测因素和性别特异性预测因素：EuroSpA协作组的研究结果
Jette Heberg,Stylianos Georgiadis,Zohra Ahmadzay et al.
Jette Heberg et al.
Objective: Identifying patient characteristics that predict treatment response in psoriatic arthritis (PsA) may help optimise treat-to-target strategies. We aimed to explore overall and sex-specific predictors of secukinu...
Targeted Therapy, Untargeted Rash: Insights From a GRAPPA Workshop on Immune Shifts in Psoriatic Disease [0.03%]
靶向治疗与非特异性皮疹——关于银屑病免疫偏移的GRAPPA研讨会心得
Leandro Linhares Leite,André L Ribeiro,Jeffrey Chau et al.
Leandro Linhares Leite et al.
The increasing use of targeted immunomodulatory therapies for psoriasis and atopic dermatitis has transformed disease management. However, paradoxical and treatment-induced cutaneous adverse and musculoskeletal events are being increasingly...
Canadian Rheumatology Association Annual Scientific Meeting Halifax Convention Centre, Halifax, Nova Scotia, Canada, April 16-19, 2026 [0.03%]
2026年加拿大风湿病协会年度科学会议加拿大新斯科舍省哈利法克斯 convention centre举行会议时间：2026年4月16日至19日
Canadian Rheumatology Association
Canadian Rheumatology Association
The 80th Annual Meeting of the Canadian Rheumatology Association took place at the Halifax Convention Centre in Halifax, Nova Scotia, from April 16 to 19, 2026. The event featured a comprehensive program of original research presentations, ...
Does the ACR/EULAR Total Improvement Score reflect how individuals with autoimmune inflammatory myopathies feel and function? [0.03%]
ACR/EULAR总改善评分能否反映自身免疫性炎性肌病患者的感受和功能状况？
Valérie Leclair,Claudie Berger,Maude Bouchard-Marmen et al.
Valérie Leclair et al.
Objective: Little is known as to whether the American College of Rheumatology/European Alliance of Associations for Rheumatology Total Improvement Score (TIS) reflects how patients in the autoimmune inflammatory myopathie...
Uncharted Territory: Adult-Onset Autoinflammatory Syndrome With a Newly Identified Mutation in the Coatomer WD-Associated Region of COPA Gene [0.03%]
未知领域：COPA基因包蛋白WD结构域关联区新突变引起的成人期起病自身炎症综合征
Paula García-Escudero,Ainhara Iturricha Ochoa de Echaguen,Sara Beltrán de Otalora García et al.
Paula García-Escudero et al.
Early-Onset Calcium Pyrophosphate Disease Associated With Genetic Hypomagnesemia: Beyond Gitelman Syndrome [0.03%]
与遗传性低镁血症相关的早期钙焦磷酸盐病：超越Gitelman综合征
Shay Brikman,Yoav Zehavi,Stavit Allon Shalev et al.
Shay Brikman et al.
Adam Amlani,Alexandra Saltman
Adam Amlani